Excess mortality due to Covid-19? A comparison of total mortality in 2020 with total mortality in 2016 to 2019 in Germany, Sweden and Spain.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
03
05
2021
accepted:
17
07
2021
entrez:
3
8
2021
pubmed:
4
8
2021
medline:
18
8
2021
Statut:
epublish
Résumé
Excess mortality is a suitable indicator of health consequences of COVID-19 because death from any cause is clearly defined contrary to death from Covid-19. We compared the overall mortality in 2020 with the overall mortality in 2016 to 2019 in Germany, Sweden and Spain. Contrary to other studies, we also took the demographic development between 2016 and 2020 and increasing life expectancy into account. Using death and population figures from the EUROSTAT database, we estimated weekly and cumulative Standardized Mortality Ratios (SMR) with 95% confidence intervals (CI) for the year 2020. We applied two approaches to calculate weekly numbers of death expected in 2020: first, we used mean weekly mortality rates from 2016 to 2019 as expected mortality rates for 2020, and, second, to consider increasing life expectancy, we calculated expected mortality rates for 2020 by extrapolation from mortality rates from 2016 to 2019. In the first approach, the cumulative SMRs show that in Germany and Sweden there was no or little excess mortality in 2020 (SMR = 0.976 (95% CI: 0.974-0.978), and 1.030 (1.023-1.036), respectively), while in Spain the excess mortality was 14.8% (1.148 (1.144-1.151)). In the second approach, the corresponding SMRs for Germany and Sweden increased to 1.009 (1.007-1.011) and 1.083 (1.076-1.090), respectively, whereas results for Spain were virtually unchanged. In 2020, there was barely any excess mortality in Germany for both approaches. In Sweden, excess mortality was 3% without, and 8% with consideration of increasing life expectancy.
Identifiants
pubmed: 34343210
doi: 10.1371/journal.pone.0255540
pii: PONE-D-21-14589
pmc: PMC8330914
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0255540Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Scand J Public Health. 2021 Feb;49(1):69-78
pubmed: 33413051
Eur J Public Health. 2021 Feb 1;31(1):17-22
pubmed: 33169145
J Infect. 2021 Mar;82(3):414-451
pubmed: 33115657
Biomark Med. 2020 Jun;14(9):713-716
pubmed: 32426991
J R Soc Med. 2020 Sep;113(9):329-334
pubmed: 32910871
J Infect. 2020 Nov;81(5):797-801
pubmed: 32956730
Euro Surveill. 2020 Jul;25(26):
pubmed: 32643601
Ther Adv Infect Dis. 2020 Jun 4;7:2049936120932755
pubmed: 32547741
Lancet Diabetes Endocrinol. 2020 Sep;8(9):782-792
pubmed: 32687793
Lancet Diabetes Endocrinol. 2020 Jul;8(7):562-564
pubmed: 32437642
Science. 2020 Oct 9;370(6513):159-163
pubmed: 33033200
Eur J Heart Fail. 2020 Dec;22(12):2190-2201
pubmed: 33135851
Oncol Res Treat. 2021;44(3):71-75
pubmed: 33333506